Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

493.22
+10.152.10%
Post-market: 494.000.7800+0.16%19:59 EDT
Volume:1.50M
Turnover:740.33M
Market Cap:53.27B
PE:12.51
High:499.88
Open:485.54
Low:485.00
Close:483.07
Loading ...
Aug 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 08, 2024

Major Issues Report

Form 8-K - Current report
Jul 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 20, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 21, 2024

Correspondence

Form CORRESP - Correspondence
May 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 02, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2024

Major Issues Report

Form 8-K - Current report
May 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities